Osimertinib, the winner, but cannot yet take it all
Ann Transl Med
.
2018 Feb;6(3):61.
doi: 10.21037/atm.2017.12.27.
Authors
Shinkyo Yoon
1
,
Jihoon Kang
1
,
Dae Ho Lee
1
Affiliation
1
Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
PMID:
29611548
PMCID:
PMC5879536
DOI:
10.21037/atm.2017.12.27
No abstract available
Publication types
Editorial
Comment